Tasigna (nilotinib), a cancer treatment in wide use across the globe, has been linked to the deadly vascular condition known as atherosclerosis. Marked by a narrowing of the veins, Tasigna atherosclerosis emerges rapidly with little warning and can result in tissue death, leading to limb amputation, coronary artery disease, and death. Research first showed a connection between Tasigna and atherosclerosis in 2011, but atherosclerosis has not been added to the Tasigna side effects list. Many Americans have consented to take this powerful cancer drug to treat Philadelphia chromosome-positive chronic myeloid leukemia without knowledge of serious and potentially life-threatening Tasigna side effects.

Tasigna, a product of the Swiss pharmaceutical company Novartis, was approved by the FDA in 2010. Tasigna atherosclerosis lawsuits are not the first legal troubles Tasigna has caused for the company. In 2013, Novartis paid $390 million to resolve a Justice Department case for the payment of illegal kickbacks to physicians prescribing Tasigna and misbranding and false advertising of the drug. Perhaps only issuing Tasigna atherosclerosis warnings when forced to do so, Novartis acknowledged Tasigna vascular side effects in Canada in 2013 but has never warned the American medical community. Tasigna maintains its position as a top-ten-selling cancer drug worldwide, bringing Novartis more than $1.7 billion in sales in 2016.

Persons and family members of persons who suffered from Tasigna atherosclerosis, amputation, peripheral artery disease, or another serious Tasigna side effect may be eligible for compensation for harm and suffering by filing a Tasigna lawsuit. As a leading medical products liability firm, our Tasigna attorneys have a strong track record of winning major cases on behalf of American consumers harmed by the actions of pharmaceutical giants. Our Tasigna lawyers are offering free, no-obligation Tasigna atherosclerosis case reviews to persons and family members of persons who suffered from cardiovascular problems after taking Tasigna.

Tasigna Side Effects

Severe and fatal Tasigna complications now include atherosclerosis, peripheral artery disease, limb amputation, and death, according to medical research. The risk of serious Tasigna complications has been documented in multiple peer-reviewed medical journals since 2011. Novartis warned Canadians of the risk of cardiovascular Tasigna side effects in 2013, yet has never warned American consumers. Read for full information on Tasigna complications, including cardiovascular problems such as rapid-onset atherosclerosis, peripheral arterial disease, limb amputation, and death. Read the full Tasigna complications information.

Tasigna Atherosclerosis

The risk of Tasigna atherosclerosis was detected in clinical studies published in 2011, and a Tasigna atherosclerosis warning was added to the drug’s warning label in 2013. However, many Americans are unaware of the risk of Tasigna atherosclerosis and continue to consent to using this powerful cancer drug without full knowledge of the risks. Rapid onset atherosclerosis from Tasigna can result in tissue death and the need for limb amputation, as well as other cardiovascular problems, peripheral arterial disease, and death. Read for full Tasigna atherosclerosis warning information.

Tasigna Lawsuits

Persons and family members of persons who have suffered from Tasigna atherosclerosis, amputation, or peripheral arterial disease may be entitled to compensation through filing Tasigna lawsuits against Novartis. Our lawyers handling Tasigna atherosclerosis lawsuits are offering no-cost, no-obligation case reviews to persons who match this description. Our attorneys believe that filing Tasigna lawsuits against Novartis is the only means to recover compensation for suffering and loss and hold the drugmaker responsible. Our lawyers handling Tasigna lawsuits work on contingency, meaning you pay nothing unless we win compensation for you.

Tasigna Lawsuit FAQs

Compiled by attorneys handling Tasigna lawsuit claims, the FAQ provides answers that will apply to most common Tasigna lawsuit questions for filing a claim anywhere in the United States. To discuss the specifics of your situation with an experienced attorney handling Tasigna lawsuit claims, please contact our firm directly. Anyone who has suffered from Tasigna complications qualifies for a no-cost, no-obligation Tasigna lawsuit case review. Read the full Tasigna lawsuit questions and answers.

Tasigna Attorneys

As experts in the realm of product liability litigation, our Tasigna lawyers understand that choosing an attorney is a significant decision. Our goal is to provide you with resources and information whether or not you choose to work with our Tasigna lawyers. Backed by a large national firm, our Tasigna attorney team works tirelessly to provide premier legal services and pursue justice on behalf of our clients. Contact a Tasigna lawyer for a free, no-obligation case review. Read full Tasigna attorney information for filing a lawsuit against Novartis.

Tasigna FAQs

What is the class action lawsuit against Tasigna?

Tasigna is a type of cancer drug called a tyrosine kinase inhibitor (TKI). The drug is a type of targeted therapy that is made by the pharmaceutical company Novartis and is approved for the treatment of chromosome-positive chronic myelogenous leukemia (CML). 

CML is a rare type of cancer that starts in the bone marrow. Multiple changes in the standard of care for CML patients have turned this potentially fatal disease into a manageable chronic condition for many patients, largely thanks to treatments like TKI therapies. 

However, over the years, thousands of reports of injuries and fatalities have been reported to the U.S. Food and Drug Administration (FDA) by patients treated with Tasigna. Most of these adverse events are related to severe or deadly cardiovascular problems that patients have suffered after taking Tasigna. 

Some injured consumers have joined class action litigation against Novartis. Others have filed individual lawsuits against the pharmaceutical company. 

Current litigation against Tasigna alleges that Novartis intentionally failed to adequately warn consumers about the cardiovascular risks associated with taking the targeted therapy. These lawsuits also assert that Novartis violated its duty of care to consumers and used illegal marketing tactics to sell a product that it knew was linked to serious heart conditions.  

What are the side effects of Tasigna?

Every drug has side effects. However, drug manufacturers have a legal duty to give full warning to consumers of those risks and side effects. When a drug company fails in this duty, it can      be liable if consumers are injured by one of these undisclosed side effects. 

There are several types of cardiovascular-related injuries that consumers have reported after taking Tasigna. One of the most notable injuries alleged by plaintiffs (injured individuals) in ongoing class action litigation is a hardening of the arteries, also known as atherosclerosis.

Atherosclerosis occurs when plaque builds up in the inside lining of the arteries. If atherosclerosis is not detected or is left untreated, patients can suffer other catastrophic or potentially deadly complications, including stroke and heart attack. 

Myocardial ischemia is another related condition commonly reported by Tasigna plaintiffs. This heart condition happens when blood flow can’t transmit properly into the heart muscle because of plaque in the arteries, creating a significant risk of a heart attack. 

Other conditions that have been reported after taking Tasigna include stroke, blood clots, narrowing of the arteries, and peripheral artery disease. 

Can I file a lawsuit if I or a loved one suffered from atherosclerosis while taking Tasigna?

If you or a loved one were prescribed Tasigna and were diagnosed with atherosclerosis or other cardiovascular issues after taking the drug, you or they may be eligible to file a lawsuit seeking monetary damages. Compensation could help you recover the value of your economic and non-economic losses arising from your injuries. 

For example, economic losses could include your medical bills and lost earning ability from your injuries. Non-economic losses, on the other hand, could include your pain and suffering from your injury. The degree and type of compensation available will depend on the severity of your injuries and the unique losses you have sustained, among other factors. 

Are there any specific criteria for eligibility to join the Tasigna lawsuit?

Some plaintiffs have opted to take legal action against Novartis through the class action process. However, individual cases are also being filed against the drugmaker. It is likely that these claims will be consolidated through a legal process known as multi-district litigation. 

Multi-district litigation is similar to a class action lawsuit in the sense that these are claims involving large groups of individuals who have been injured by the same product. However, a class action lawsuit is filed as a single legal action. This means that any award of damages is divided among all the injured plaintiffs and not necessarily equally. Usually, the most injured plaintiffs receive the highest amount of damages in a class action lawsuit. 

In the case of multi-district litigation, cases are grouped together for parts of the legal process, but injured individuals each maintain their own separate lawsuits. For someone injured by Tasigna whose case is combined into multi-district litigation, any compensation award would be based on the severity of their specific injuries and losses. 

If you or a family member took Tasigna and subsequently suffered from atherosclerosis or another related cardiovascular disorder, you may be eligible to join ongoing litigation. A qualified attorney could evaluate your prospective case and advise you of your best legal options. 

Is there a statute of limitations for filing a Tasigna lawsuit?

Every state has its own statute of limitations to file a lawsuit for a drug-related injury. In Missouri, the statute of limitations is usually five years from the date of the injury. Of course, determining when this five-year period began to run can be complicated with injuries from a dangerous or defective drug. A knowledgeable legal professional at OnderLaw can tell you what the applicable statute of limitations is for your potential Tasigna case.